The Regents of the University of California;United States Government Department Of Veterans Affairs
发明人:
申请号：
EP11745457.9
公开号：
EP2536433B1
申请日:
2011.02.22
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
A method is disclosed for treating diseases or disorders of the eye involving undesired expression of vascular endothelial growth factor (VEGF) by administration of endothelial membrane protein 2 (EMP2) inhibitor. The present invention relates to the direct treatment of macular degeneration, particularly age-related macular degeneration (AMD), by administering an EMP2 inhibitor intraocularly or systemically.
